• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of April 9, 2014

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 27437-207-03.
Recall Number D-1187-2014
Classification Class III
Code Info Lot #s: F300736 Exp. February 2015, F300740 Exp. February 2015, F300741 Exp. February 2015
Product Distributed Qty 5,172 bottles
Reason For Recall Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.

Event Detail

Event Id 67462
Product Type Drugs
Status Ongoing
Recalling Firm Lupin Pharmaceuticals Inc.
City Baltimore
State MD
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2014-01-27
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide
-
-